Last update 31 May 2025

Naphazoline hydrochloride/Hypromellose

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PRO-185
Target
α-adrenergic receptor
Action
agonists
Mechanism
α-adrenergic receptor agonists(Alpha adrenergic receptor agonists)
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Hyperemia
Originator Organization
Laboratorios Sophia SA de CVLaboratorios Sophia SA de CV
Active Organization-
Inactive Organization
Laboratorios Sophia SA de CVLaboratorios Sophia SA de CV
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC14H15ClN2
InChIKeyDJDFFEBSKJCGHC-UHFFFAOYSA-N
CAS Registry550-99-2

Related

1
Clinical Trials associated with Naphazoline hydrochloride/Hypromellose
NCT05470868
/ CompletedPhase 1
Phase I Clinical Study, to Evaluate the Safety and Tolerability of the Ophthalmic Solution PRO-185 When Applied on the Ocular Surface of Healthy Volunteers
100 Clinical Results associated with Naphazoline hydrochloride/Hypromellose
Login to view more data
100 Translational Medicine associated with Naphazoline hydrochloride/Hypromellose
Login to view more data
100 Patents (Medical) associated with Naphazoline hydrochloride/Hypromellose
Login to view more data
100 Deals associated with Naphazoline hydrochloride/Hypromellose
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperemiaPhase 1
Mexico
Laboratorios Sophia SA de CVLaboratorios Sophia SA de CV
04 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free